DocWire News Editors

DocwireNews

Patients have been treated in the U.S. using <a href="https://www.docwirenews.com/docwire-pick/5-novel-uses-of-crispr-gene-editing/">CRISPR gene-editing</a> for the first time, with a University of Pennsylvania study utilizing the technique in treating cancer. Scientists have been hopeful that CRISPR could be used to treat many diseases, and these Penn researchers are optimistic about the trial.Two patients were treated with the powerful gene-editing tool, one with sarcoma and one with multiple myeloma. Both of these patients had underwent standard treatment but were unable to eradicate their disease, and are instead partaking in the first case of CRISPR use in humans in the U.S. With recent news of a <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/chinese-researcher-claims-controversial-creation-of-first-gene-edited-babies/">Chinese scientist using CRISPR</a> to make genetically modified babies there is much controversy around the technology, however the science community is eager to see how the technique can help those with disease.<iframe loading="lazy" src="https://www.youtube.com/embed/th0vnOmFltc" width="696" height="391" frameborder="0" allowfullscreen="allowfullscreen"></iframe>&ldquo;2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense,&rdquo; said Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley.To this point very few studies have attempted to use <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/novel-crispr-cas3-genetic-editing-holds-potential-in-curing-disease/">CRISPR</a> to treat disease, with a majority of them taking place in China. Like this recent Penn trial, these studies aimed to use the technique in treating cancer.This specific trial taking place in Philadelphia involves the removal of immune system cells from patients, <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/targeting-epigenetics-to-reverse-memory-loss-in-alzheimers-patients/">genetic</a> modification of them, then re-implantation. The goal is that these CRISPR-edited cells will be able to target and destroy the cancer cells.Though only two patients have received this treatment, the study was approved to eventually treat 18 patients. No information has been released regarding how well the treatment is working.&ldquo;Findings from this research study will be shared at an appropriate time via medical meeting presentation or peer-reviewed publication,&rdquo; wrote a Penn spokesperson in an email to NPR.<a href="https://www.docwirenews.com/docwire-pick/gene-therapy-technology-advancing-rapidly/">READ MORE: Gene Therapy Technology Advancing Rapidly</a>Outside of this trial, scientists elsewhere in the U.S., Europe, and Canada are planning a handful of studies analyze CRISPR as a treatment for various diseases. Two of these trials are designed to treat genetic blood disorders, one being sickle cell disease and the other a similar condition called beta thalassemia. These trials are sponsored by CRISPR Therapeutics in Cambridge, Massachusetts, and Vertex Pharmaceuticals in Boston.The beta thalassemia patient was actually treated already in Germany using a CRISPR gene-editing technique known as <a href="http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-vertex-announce-progress-clinical">CTX001</a>. Other patients may soon receive similar CRISPR therapy at that hospital and another clinic in Germany, followed by other patients at centers in Toronto and London.Additionally, the first sickle-cell patients in the U.S. may soon receive CRISPR gene therapy in Nashville, San Antonio, and New York. Another study, sponsored by Editas Medicine in Cambridge, Massachusetts, plans to use the technique to treat a heritable form of blindness known as Leber congenital amaurosis.<blockquote class="twitter-tweet" data-lang="en">
We&rsquo;re about to see what CRISPR can do against cancer. <a href="https://t.co/hVxoBfbVv5">https://t.co/hVxoBfbVv5</a>
&mdash; Futurism (@futurism) <a href="https://twitter.com/futurism/status/1118574969238294528?ref_src=twsrc%5Etfw">April 17, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.npr.org/sections/health-shots/2019/04/16/712402435/first-u-s-patients-treated-with-crispr-as-gene-editing-human-trials-get-underway">NPR</a>, <a href="http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-vertex-announce-progress-clinical">CRISPR Therapeutics</a>

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

First U.S. Cancer Patients Treated with CRISPR Gene-Editing Therapy

Future of Medicine

Patients have been treated in the U.S. using CRISPR gene-editing for the first time, with a University of Pennsylvania study utilizing the technique in treating cancer. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe